Editing the Central Nervous System Through CRISPR/Cas9 Systems

The translational gap to treatments based on gene therapy has been reduced in recent years because of improvements in gene editing tools, such as the CRISPR/Cas9 system and its variations. This has allowed the development of more precise therapies for neurodegenerative diseases, where access is priv...

Descripción completa

Detalles Bibliográficos
Autores principales: Cota-Coronado, Agustin, Díaz-Martínez, Néstor Fabián, Padilla-Camberos, Eduardo, Díaz-Martínez, N. Emmanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546027/
https://www.ncbi.nlm.nih.gov/pubmed/31191241
http://dx.doi.org/10.3389/fnmol.2019.00110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546027/
https://www.ncbi.nlm.nih.gov/pubmed/31191241
http://dx.doi.org/10.3389/fnmol.2019.00110

Ejemplares similares